ALDER BIOPHARMACEUTICALS INC (24) | Human Resources (7)
Browse by Subcategory
Recent Contracts
-
Alder BioPharmaceuticals, Inc. Executive Severance Benefit Plan, effective October 18, 2019
(Filed With SEC on October 22, 2019)
-
Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Annual Grants)
(Filed With SEC on August 6, 2019)
-
Transition and Consulting Agreement between Alder BioPharmaceuticals, Inc. and John A. Latham, Ph.D. dated March 28, 2019
(Filed With SEC on May 2, 2019)
-
Compensation Information for Non-Employee Directors
(Filed With SEC on May 2, 2019)
-
Transition Agreement between Alder BioPharmaceuticals, Inc. and Elisabeth A. Sandoval, dated November 2, 2018
(Filed With SEC on February 25, 2019)
-
Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Initial Grants)
(Filed With SEC on August 6, 2019)
-
Amendment to Offer Letter between Alder BioPharmaceuticals, Inc. and Carlos E. Campoy dated February 7, 2019. X 10.32+ Amended and Restated Executive Severance Benefit Plan
(Filed With SEC on February 25, 2019)